The clinical trial to study a new drug, AP-2.

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-524480-21-00

Enrollment

Registered

2026-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALS and related disorders like frontotemporal dementia and Alexander disease.

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

None listed

Source: EU CTIS · Data processed: Mar 11, 2026